Sunshine Biopharma (SBFM) Retained Earnings (2010 - 2026)
Sunshine Biopharma's (SBFM) quarterly Retained Earnings came in at $98.1 million in Q1 2026, up 12305.11% YoY from N/an in Q1 2025, and up 150310.52% on a QoQ basis from -$65309.0 in Q4 2025.
Sunshine Biopharma (SBFM) Retained Earnings (2010 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 16 years of Retained Earnings data on file, last reported at $98.1 million in Q1 2026.
- Quarterly Retained Earnings rose 12305.11% year-over-year to $98.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $98.1 million (up 12305.11% YoY) and the FY2025 annual result came in at -$65309.0, up 99.91% from the prior year.
- Retained Earnings climbed to $98.1 million in Q1 2026, from -$65309.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $98.1 million in Q1 2026 to a low of -$72.0 million in Q2 2025.
- A 5-year average of $15.1 million and a median of $152400.0 in 2024 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings tumbled 295794.47% — and 2024, when it soared 44748.56%.
- Tracing SBFM's Retained Earnings over 5 years: stood at -$59.4 million in 2022, then surged by 101.17% to $696105.0 in 2023, then plunged by 10018.01% to -$69.0 million in 2024, then jumped by 99.91% to -$65309.0 in 2025, then jumped by 150310.52% to $98.1 million in 2026.
- The last three Retained Earnings figures came in at $98.1 million (Q1 2026), -$65309.0 (Q4 2025), and -$320841.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.03 Bn | 43.06 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 42.97 Bn | 39.31 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.63 Bn | 29.95 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.54 Bn | 22.74 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.33 Bn | 19.67 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.68 Bn | 17.80 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.89 Bn | 11.36 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.08 Bn | 9.92 Bn | - | 3.75 Bn |
| 10 | Sunshine Biopharma | 1.57 Mn | -12.18 Mn | 2.43 Mn | 106.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 106.00 Mn |
| Mar 31, 2026 | 98.10 Mn |
| Dec 31, 2025 | -65,309.00 |
| Sep 30, 2025 | -320,841.00 |
| Jun 30, 2025 | -71.99 Mn |
| Mar 31, 2025 | -803,770.00 |
| Dec 31, 2024 | -69.04 Mn |
| Sep 30, 2024 | 91.74 Mn |
| Jun 30, 2024 | 89.84 Mn |
| Mar 31, 2024 | 152,400.00 |
| Dec 31, 2023 | 696,105.00 |
| Sep 30, 2023 | 204,549.00 |
| Jun 30, 2023 | 84.42 Mn |
| Mar 31, 2023 | 80.34 Mn |
| Dec 31, 2022 | -59.40 Mn |
| Sep 30, 2022 | -79,903.00 |
| Jun 30, 2022 | -34.43 Mn |
| Mar 31, 2022 | 47.22 Mn |
| Dec 31, 2021 | -32.66 Mn |
| Sep 30, 2021 | 31.56 Mn |